LENSAR, Inc.'s (NASDAQ:LNSR) Path To Profitability [Yahoo! Finance]
LENSAR, Inc. (LNSR)
Company Research
Source: Yahoo! Finance
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company's loss has recently broadened since it announced a US$14m loss in the full financial year, compared to the latest trailing-twelve-month loss of US$17m, moving it further away from breakeven. As path to profitability is the topic on LENSAR's investors mind, we've decided to gauge market sentiment. Below we will provide a high-level summary of the industry analysts' expectations for the company. View our latest analysis for LENSAR According to the 2 industry analysts covering LENSAR, the consensus is that breakeven is near. They anticipate the company to incur a final loss in 2025, before generating positive profits of US$2.7m in 2026. So, the company is predicted to breakeven approximately 2 years from today. What rate will the compa
Show less
Read more
Impact Snapshot
Event Time:
LNSR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LNSR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LNSR alerts
High impacting LENSAR, Inc. news events
Weekly update
A roundup of the hottest topics
LNSR
News
- LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day [Yahoo! Finance]Yahoo! Finance
- LENSAR to Participate in the BTIG 4th Annual Ophthalmology DayGlobeNewswire
- LENSAR Inc (LNSR) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion [Yahoo! Finance]Yahoo! Finance
- LENSAR Reports Third Quarter 2024 Results and Provides Business UpdateGlobeNewswire
LNSR
Sec Filings
- 11/14/24 - Form SC
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- LNSR's page on the SEC website